Amgen expands Indian distribution

Dr. Reddy%27s Laboratories Ltd. (NYSE:RDY) entered a collaboration with Amgen Inc. (NASDAQ:AMGN) to market and distribute Amgen's Kyprolis carfilzomib, Blincyto blinatumomab and Repatha evolocumab in India. Financial details were not disclosed.

Amgen spokesperson Kristen Davis told BioCentury that the three drugs were chosen for the Indian market because they would address unmet needs in the population. Amgen said it partnered with Dr. Reddy%27s for its "significant experience serving oncology and cardiovascular patients in India." ...